These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Atria-selective antiarrhythmic drugs in need of alliance partners. Peyronnet R; Ravens U Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Voigt N; Rozmaritsa N; Trausch A; Zimniak T; Christ T; Wettwer E; Matschke K; Dobrev D; Ravens U Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):251-9. PubMed ID: 19760273 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept. Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model. Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium. Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531 [TBL] [Abstract][Full Text] [Related]